QS Investors LLC held its position in MEDIFAST INC (NYSE:MED) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 42,416 shares of the specialty retailer’s stock at the end of the 2nd quarter. QS Investors LLC owned approximately 0.36% of MEDIFAST INC worth $1,759,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the company. Renaissance Technologies LLC increased its position in shares of MEDIFAST INC by 0.3% in the first quarter. Renaissance Technologies LLC now owns 954,000 shares of the specialty retailer’s stock valued at $42,329,000 after buying an additional 2,500 shares in the last quarter. Engaged Capital LLC increased its position in shares of MEDIFAST INC by 2.2% in the first quarter. Engaged Capital LLC now owns 789,549 shares of the specialty retailer’s stock valued at $35,032,000 after buying an additional 17,084 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of MEDIFAST INC by 4.4% in the second quarter. Dimensional Fund Advisors LP now owns 659,896 shares of the specialty retailer’s stock valued at $27,366,000 after buying an additional 27,685 shares in the last quarter. Vanguard Group Inc. increased its position in shares of MEDIFAST INC by 2.2% in the second quarter. Vanguard Group Inc. now owns 657,254 shares of the specialty retailer’s stock valued at $27,256,000 after buying an additional 13,982 shares in the last quarter. Finally, Kennedy Capital Management Inc. increased its position in shares of MEDIFAST INC by 4.8% in the second quarter. Kennedy Capital Management Inc. now owns 398,063 shares of the specialty retailer’s stock valued at $16,508,000 after buying an additional 18,183 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

A number of research firms have recently commented on MED. Sidoti restated a “neutral” rating and issued a $55.00 price objective (up from $49.00) on shares of MEDIFAST INC in a research report on Thursday, September 21st. DA Davidson boosted their price objective on MEDIFAST INC from $65.00 to $74.00 and gave the company a “buy” rating in a research report on Friday, September 15th. Finally, BidaskClub upgraded MEDIFAST INC from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th.

TRADEMARK VIOLATION WARNING: “QS Investors LLC Continues to Hold Holdings in MEDIFAST INC (MED)” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://theolympiareport.com/2017/10/09/qs-investors-llc-continues-to-hold-holdings-in-medifast-inc-med.html.

Shares of MEDIFAST INC (NYSE MED) opened at 60.30 on Monday. The stock has a 50 day moving average price of $56.81 and a 200-day moving average price of $46.89. MEDIFAST INC has a 52-week low of $36.70 and a 52-week high of $61.31. The stock has a market capitalization of $719.38 million, a PE ratio of 30.30 and a beta of 0.46.

MEDIFAST INC (NYSE:MED) last posted its quarterly earnings results on Tuesday, August 8th. The specialty retailer reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. The business had revenue of $75.70 million during the quarter, compared to analysts’ expectations of $71.96 million. MEDIFAST INC had a return on equity of 24.25% and a net margin of 8.62%. The company’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same period last year, the firm earned $0.63 EPS. On average, equities research analysts anticipate that MEDIFAST INC will post $2.12 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 9th. Stockholders of record on Friday, September 22nd will be issued a $0.32 dividend. The ex-dividend date is Thursday, September 21st. This represents a $1.28 annualized dividend and a dividend yield of 2.12%. MEDIFAST INC’s dividend payout ratio is currently 64.32%.

MEDIFAST INC Profile

Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.

Want to see what other hedge funds are holding MED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDIFAST INC (NYSE:MED).

Institutional Ownership by Quarter for MEDIFAST INC (NYSE:MED)

Receive News & Ratings for MEDIFAST INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related companies with Analyst Ratings Network's FREE daily email newsletter.